Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Holding(s) in Company

15 Nov 2005 17:22

Akers Biosciences, Inc.15 November 2005 Akers Biosciences, Inc. (the "Company") The Company received notification on 14 November 2005 that, following recentpurchases, John Harvey now owns 3,475,000 ordinary shares in the Company. This holding represents 6.5 per cent. of the issued share capital of theCompany. End This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.